510(k) Report

510(k) · Cleared

Cleared

XSTAT 30, 3-Pack; XSTAT 30, 1-Pack; XSTAT 12, 3 Pack; XSTAT 12, 1 Pack

K170334510(k) TraditionalCleared May 1, 201788-day reviewClass II21 CFR 878.4452

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Revmedx, Inc. · PGZ Non-Absorbable, Expandable, Hemostatic Sponge For Temporary Internal Use

Cleared on May 1, 2017 as substantially equivalent to K152624 (Revmedx, Inc., 2015) and 1 other predicate after an 88-day review. Its family tree reaches back 3 generations to 2014. 3 later devices descend from it.

Decided
May 1, 2017
Review
88 days
Class
Class II
Product code
PGZ
Recalls
None
Predicates
2

Its longest line of descent runs back 3 generations to DEN130016 (2014). 3 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2018: 1 descendant cleared2021: 1 descendant cleared2025: 1 descendant clearedDEN130016 · XSTAT · Revmedx, Inc. · 2014K152624 · Xstat 30, 3-Pack, Xstat 30, 1-Pack · Revmedx, Inc. · 2015K161020 · XSTAT-12, 3-Pack, XSTAT-12, 1-Pack · Revmedx, Inc. · 20162010201520202025
Descendants, by generation 1 generation forward: 1 descendant2 generations forward: 1 descendant3 generations forward: 1 descendant K161020 · XSTAT-12, 3-Pack, XSTAT-12, 1-Pack · Revmedx, Inc. · 2016K152624 · Xstat 30, 3-Pack, Xstat 30, 1-Pack · Revmedx, Inc. · 2015DEN130016 · XSTAT · Revmedx, Inc. · 20140
  1. Root · 3 generations backDEN130016 XSTATRevmedx, Inc. · 2014
  2. 2 generations backK152624 Xstat 30, 3-Pack, Xstat 30, 1-PackRevmedx, Inc. · 2015
  3. 1 generation backK161020 XSTAT-12, 3-Pack, XSTAT-12, 1-PackRevmedx, Inc. · 2016
  4. This deviceK170334 XSTAT 30, 3-Pack; XSTAT 30, 1-Pack; XSTAT 12, 3 Pack; XSTAT 12, 1 PackRevmedx, Inc. · 2017
  5. Descendant · cites it directly · 2 of its ownK180051 XSTAT 30, 1-PackRevmedx, Inc. · 2018
  6. Descendant · 2 generations on · 1 of its ownK210676 XSTAT 30 PouchRevmedx, Inc. · 2021
  7. Descendant · 3 generations on · 0 of its ownK253290 Xstat P15Revmedx, Inc. · 2025

Most influential descendants

Showing 3 of 3 · See all
  • K180051XSTAT 30, 1-PackRevmedx, Inc. · 2018 · cites it directly2descendants
  • K210676XSTAT 30 PouchRevmedx, Inc. · 2021 · 2 generations on1descendant
  • K253290Xstat P15Revmedx, Inc. · 2025 · 3 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3DEN130016XSTATRevmedx, Inc.2014—
−2K152624Xstat 30, 3-Pack, Xstat 30, 1-PackRevmedx, Inc.2015—
−1K161020XSTAT-12, 3-Pack, XSTAT-12, 1-PackRevmedx, Inc.2016—
0 (this device)K170334XSTAT 30, 3-Pack; XSTAT 30, 1-Pack; XSTAT 12, 3 Pack; XSTAT 12, 1 PackRevmedx, Inc.2017—
+1K180051XSTAT 30, 1-PackRevmedx, Inc.2018—
+2K210676XSTAT 30 PouchRevmedx, Inc.2021—
+3K253290Xstat P15Revmedx, Inc.2025—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201810
202110
202510
FIG. 1 — Lineage of K170334, 2014–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PGZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new PGZ device

  1. #1 K253290 Xstat P15score 11.8 · 6 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K152624Xstat 30, 3-Pack, Xstat 30, 1-Pack
Summary page 5
…e: 21 CFR 878.4452; PGZ, Class II (1) 21 CFR 878.4014, NAB, Class I (2) NOTE: Product Classification is Class II Predicate Devices: XSTAT 30 (K152624) XSTAT 12 (K161020) Reference Device: XSTAT (DEN13006/K130218) Intended Use / Indications for Use: Intended Use - Devic…
Revmedx, Inc.2015—
*K161020XSTAT-12, 3-Pack, XSTAT-12, 1-Pack
Summary page 5
…PGZ, Class II (1) 21 CFR 878.4014, NAB, Class I (2) NOTE: Product Classification is Class II Predicate Devices: XSTAT 30 (K152624) XSTAT 12 (K161020) Reference Device: XSTAT (DEN13006/K130218) Intended Use / Indications for Use: Intended Use - Device #1: The XSTAT 30 is inte…
Revmedx, Inc.2016—
†K130218XSTAT—

Also cleared against K152624: 1 other device →

What descends from it? (3)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K180051XSTAT 30, 1-PackRevmedx, Inc.20182

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 3 years and passes through 1 company; a new generation was cleared every 9 months on median.
  • None of the 3 ancestors has a recall.
  • Of its descendants, K180051 (Revmedx, Inc., 2018) has gone furthest, with 2 descendants of its own.
  • 1 other device also cites its predicate K152624.

How does its category compare?

All PGZ devices

PGZ Non-Absorbable, Expandable, Hemostatic Sponge For Temporary Internal Use: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.

FDA decisions per year · PGZ

1in 2025

2014: 12015: 12016: 12017: 12018: 12021: 12025: 1
2007high 1 (2014) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PGZ

Too few PGZ 510(k)s in any year since 2007 to give a median.

Recalls per year · PGZ

No recall names PGZ since 2007.

Adverse event reports per year · PGZ

No MAUDE report names PGZ since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20141—00
20151—00
20161—00
20171—00
20181—00
20190—00
20200—00
20211—00
20220—00
20230—00
20240—00
20251—00
20260—0—

What is it indicated for?

XSTAT 30 is a hemostatic device for the control of severe, life-threatening bleeding from wounds in the groin or axilla that are not amenable to tourniquet application in adults and adolescents. XSTAT 30 is a hemostatic device for the control of severe, life-threatening bleeding from narrow entrance extremity wounds in the arms or legs in adults and adolescents. XSTAT 30 is a temporary device for use up to four (4) hours until surgical care is acquired.…

Read the full statement (312 words)

XSTAT 30 is a hemostatic device for the control of severe, life-threatening bleeding from wounds in the groin or axilla that are not amenable to tourniquet application in adults and adolescents.

XSTAT 30 is a hemostatic device for the control of severe, life-threatening bleeding from narrow entrance extremity wounds in the arms or legs in adults and adolescents.

XSTAT 30 is a temporary device for use up to four (4) hours until surgical care is acquired. It should only be used for patients at high risk from immediate life-threatening hemodynamically significant (Advanced Trauma Life Support class 3 or 4 hemorrhagic shock) non-compressible junctional wounds or narrow entrance extremity wounds, and when definitive care at an emergency care facility cannot be achieved within minutes.

XSTAT 30 is NOT indicated for use in the thorax, the pleural cavity, the mediastinum, the abdomen, the retroperitoneal space, the sacral space, tissues above the inguinal ligament, or tissues above the clavicle.

XSTAT 12 is a hemostatic device for the control of severe, life-threatening bleeding from wounds in the groin or axilla that are not amenable to tourniquet application in adults and adolescents.

XSTAT 12 is a hemostatic device for the control of severe, life-threatening bleeding from narrow entrance extremity wounds in the arms or legs in adults and adolescents.

XSTAT 12 is a temporary device for use up to four (4) hours until surgical care is acquired. It should only be used for patients at high risk from immediate life-threatening hemodynamically significant (Advanced Trauma Life Support class 3 or 4 hemorrhagic shock) non-compressible junctional wounds or narrow entrance extremity wounds, and when definitive care at an emergency care facility cannot be achieved within minutes.

XSTAT 12 is NOT indicated for use in the thorax, the pleural cavity, the mediastinum, the abdomen, the retroperitoneal space, the sacral space, tissues above the inguinal ligament, or tissues above the clavicle.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K170334: XSTAT 30, 3-Pack; XSTAT 30, 1-Pack; XSTAT 12, 3 Pack; XSTAT 12, 1 Pack.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K170334

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026